Page Image

The Uromigos

The Uromigos, Thomas Powles, MD, and Brian Rini, MD, FASCO, highlight the latest developments in genitourinary cancers. Each podcast episode features a guest expert from around the world discussing the latest data, debates, and manuscripts relevant to the practical clinical care of GU oncology patients.

ESMO

Latest Episode

Episode 358: Tres Uramigas - News From Day 1 of #UromigosLive24 in Nashville
In this Spanish-language podcast, Drs. Maite Bourlon, Elena Castro and Cristina Suarez cover the urothelial cancer topics discussed on day 1 of Uromigos Live 2024. The impact of the NIAGARA study on chemotherapy plus immunotherapy in neoadjuvant muscle-invasive urothelial carcinoma is discussed, along with the use of adjuvant pembrolizumab based on AMBASSADOR study data and the search for biomarkers. ...
Advertisement
Advertisement

The Uromigos: Live and Unplugged 2023

Kidney Cancer Discussions

Dr. Brian Rini’s Disclosures

Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis

Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai

Stock: PTC therapeutics

Advertisement
Advertisement
Get updates from The Uromigos straight to your inbox.